Loading clinical trials...
Loading clinical trials...
A Randomized, Blinded, Placebo-controlled Trial of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Patients With Cancer Undergoing Chemotherapy
Conditions
Interventions
Shengbai Oral Formula
Inactive Placebo
Locations
1
United States
Sutter Health
Oakland, California, United States
Start Date
January 24, 2025
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2025
Last Updated
May 15, 2025
NCT05702398
NCT06066138
NCT05691465
NCT05673200
NCT05692635
NCT06305754
Lead Sponsor
Sutter Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions